Submission for OMB Review; 30-Day Comment Request: A National Survey of Nurse Coaches (NIH Clinical Center), 81787-81788 [2016-27839]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 223 / Friday, November 18, 2016 / Notices
future DMICC meetings should register
for the listserv available on the DMICC
Web site, www.diabetescommittee.gov.
Dated: November 9, 2016.
B. Tibor Roberts,
Executive Secretary, Office of Scientific
Program and Policy Analysis, National
Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2016–27825 Filed 11–17–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing and/or CoDevelopment
National Institutes of Health,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing and/or co-development in the
U.S. to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing and/or co-development.
ADDRESSES: Invention Development and
Marketing Unit, Technology Transfer
Center, National Cancer Institute, 9609
Medical Center Drive, Mail Stop 9702,
Rockville, MD 20850–9702.
FOR FURTHER INFORMATION CONTACT:
Information on licensing and codevelopment research collaborations,
and copies of the U.S. patent
applications listed below may be
obtained by contacting: Attn. Invention
Development and Marketing Unit,
Technology Transfer Center, National
Cancer Institute, 9609 Medical Center
Drive, Mail Stop 9702, Rockville, MD
20850–9702, Tel. 240–276–5515 or
email ncitechtransfer@mail.nih.gov. A
signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
SUPPLEMENTARY INFORMATION:
Technology description follows.
Title of invention: Methods of Making
and Using Dopamine D3 Receptor
Selective Antagonists/Partial Agonists
Summary of Technology: A library of
novel compounds that selectively bind
the dopamine D3 receptor have been
designed and characterized extensively.
In vivo rodent studies indicate selected
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:21 Nov 17, 2016
Jkt 241001
lead molecules may be useful to treat
drug addiction/dependence.
Description of Technology: Dopamine
is a major neurotransmitter in the
central nervous system and among other
functions is directly related to the
rewarding effects of drugs of abuse.
Dopamine signaling is mediated by D1,
D2, D3, D4 and D5 receptors. The
dopamine D3 receptor is a known target
to treat a variety of neuropsychiatric
disorders, including substance use
disorders (e.g. cocaine and opioid),
schizophrenia and depression. Despite
extensive efforts, it has proven difficult
to identify a lead molecule that
selectively binds to D3 receptors (versus
D2 receptors, for example), with the
desired pharmacological and
pharmacokinetic profile. For example,
metabolic instability or predicted
toxicity has precluded successful
translation of previously reported D3Rselective antagonists to clinical use for
cocaine abuse.
The library of compounds is designed
to have high affinity and specificity for
the dopamine D3 receptor. Preliminary
studies at National Institute of Drug
Abuse (NIDA) indicate that selected
lead compounds have promising in vivo
activity in rodents, including reduced
acquisition to self-administration of
oxycodone, inhibition of reinstatement
to oxycodone seeking, and ameliorating
naloxone-precipitated withdrawal from
oxycodone dependence.
This invention is owned by an agency
of the U.S. Government and is available
for licensing and/or co-development in
the U.S., in accordance with 35 U.S.C.
209 and 37 CFR part 404, to achieve
expeditious commercialization of
results of federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing and/or co-development.
Potential Commercial Applications:
• Treatment of Opioid Use Disorders
• Treatment of Schizophrenia
• Treatment of Bipolar Disorder
• Treatment of cannabis
(Tetrahydrocannabinol, THC)
dependence
Value Proposition: Despite extensive
efforts to develop D3 receptor-selective
compounds, it has proven difficult to
identify a ligand with the desired
pharmacological and pharmacokinetic
profile for translation to the clinic. The
D3 receptor ligands described herein
may be useful to treat a variety of
diseases, including opioid use disorders
and schizophrenia.
Development Stage: Pre-clinical (in
vivo validation).
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
81787
Inventor(s): Amy Newman and Vivek
Kumar (NIDA).
Intellectual Property: E–053–2016
United States Provisional Patent
Application No. 62/307,600, filed March
14, 2016, titled ‘‘Dopamine D3 Receptor
Selective Antagonists/Partial Agonists;
Methods of Making and Use Thereof’’.
Publications: J Med Chem. 2016 Aug
25;59(16):7634–50. doi: 10.1021/
acs.jmedchem.6b00860. Epub 2016 Aug
10.
Collaboration Opportunity:
Researchers at the NIDA seek licensing
and/or co-development research
collaborations for development of
Dopamine D3 ligands to treat opioid use
disorders.
Contact Information: Requests for
copies of the patent application or
inquiries about licensing, research
collaborations, and co-development
opportunities should be sent to John D.
Hewes, Ph.D., email: john.hewes@
nih.gov.
Dated: November 10, 2016.
John D. Hewes,
Technology Transfer Specialist, Technology
Transfer Center, National Cancer Institute.
[FR Doc. 2016–27770 Filed 11–17–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request: A National Survey
of Nurse Coaches (NIH Clinical Center)
National Institutes of Health.
Notice.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
August 22, 2016, pages 56668–9 (81 FR
56668) and allowed 60-days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received by
December 19, 2016.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
SUMMARY:
E:\FR\FM\18NON1.SGM
18NON1
81788
Federal Register / Vol. 81, No. 223 / Friday, November 18, 2016 / Notices
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Alyson Ross,
Nurse Researcher, Department of
Nursing Research and Translational
Science, NIH Clinical Center, Building
10, Room 2B07, MSC–1151, Bethesda,
Maryland, 20892 or call non-toll-free
number (301) 451–8338 or Email your
request, including your address to:
Alyson.ross@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: The NIH
Clinical Center, National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
outcomes followed, as well as the
personal benefits experienced by nurse
coaches as a result of becoming a nurse
coach. It provides information regarding
two areas of interest to the Department
of Nursing Research and Translational
Science: The collection of patientreported outcomes in novel clinical
practice areas and the physical and
psychosocial benefits of an intervention
in nurses, a professional caregiver
population. This study will provide
preliminary data and guidance in: (1)
Developing recommendations for
collecting outcomes to longitudinally
assess the effectiveness nurse coaching,
and (2) developing an intervention to
improve patient care and patient
satisfaction targeting the nursing staff at
the NIH Clinical Center.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 104.
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: A National
Survey of Nurse Coaches, 0925–NEW,
National Institutes of Health Clinical
Center (NIHCC), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The purpose of this survey is
to describe the role of Certified Nurse
Coaches in order to gain insight into
their clinical practice including: The
settings in which they work, the types
of clients/health conditions they see, the
types of client records maintained and
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hours
Certified Nurse Coaches .................................................................................
250
1
25/60
104
Total ..........................................................................................................
250
250
........................
104
Dated: November 9, 2016.
Laura M. Lee,
Project Clearance Liaison, NIH Clinical
Center, National Institutes of Health.
[FR Doc. 2016–27839 Filed 11–17–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2016–0965]
Certificate of Alternative Compliance
for the TUG MAXWELL PAUL MORAN
Coast Guard, DHS.
Notice.
AGENCY:
ACTION:
The Coast Guard announces
that the First District Prevention
Department’s Inspections and
Investigations Division has issued a
Certificate of Alternate Compliance
(COAC) from the International
Regulations for Preventing Collisions at
Sea, 1972 (72 COLREGS) for the TUG
MAXWELL PAUL MORAN as required
by statue. Due to its operations as a
harbor assistance and escort vessel it
cannot fully comply with the sidelight,
mstockstill on DSK3G9T082PROD with NOTICES
20:21 Nov 17, 2016
For
information or questions about this
notice call or email Mr. Kevin Miller,
First District Towing Vessel/Barge
Safety Specialist, U.S. Coast Guard;
telephone (617) 223–8272, email
<Kevin.L.Miller2@uscg.mil>.
SUPPLEMENTARY INFORMATION:
The United States is signatory to the
International Maritime Organization’s
International Regulations for Preventing
Collisions at Sea, 1972 (72 COLREGS),
as amended. The special construction or
purpose of some vessels makes them
FOR FURTHER INFORMATION CONTACT:
SUMMARY:
VerDate Sep<11>2014
stern light, and towing light provisions
of the 72 COLREGS without interfering
with its ability to make up and assist
other vessels. This notice promotes the
Coast Guard’s maritime safety and
stewardship missions.
ADDRESSES: Documents mentioned in
the preamble are part of docket USCG–
2016–0965. To view documents
mentioned in this preamble as being
available in the docket, go to the Federal
eRulemaking Portal at https://
www.regulations.gov, type the docket
number in the ‘‘SEARCH’’ box and click
‘‘SEARCH.’’ Click on Open Docket
Folder on the line associate with this
notice.
Jkt 241001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
unable to comply with the light, shape,
and sound signal provisions of the 72
COLREGS. Under statutory law 1 and
Coast Guard regulation,2 a vessel may
instead meet alternative requirements
and the vessel’s owner, builder,
operator, or agent may apply for a
COAC. For vessels of special
construction, the cognizant Coast Guard
District Office determines whether the
vessel for which the COAC is sought
complies as closely as possible with the
72 COLREGS, and decides whether to
issue the COAC. Once issued, a COAC
remains valid until information
supplied in the COAC application or the
COAC terms become inapplicable to the
vessel. Under the governing statute 3
and regulation,4 the Coast Guard must
publish notice of this action.
The Prevention Department’s
Inspection and Investigation Division,
U.S. Coast Guard First District hereby
finds and certifies that the TUG
MAXWELL PAUL MORAN is a vessel of
special construction or purpose, and
that, with respect to the position of the
1 33
U.S.C. 1605(c).
CFR 81.3.
3 33 U.S.C. 1605(c).
4 33 CFR 81.18.
2 33
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 81, Number 223 (Friday, November 18, 2016)]
[Notices]
[Pages 81787-81788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27839]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request: A National
Survey of Nurse Coaches (NIH Clinical Center)
AGENCY: National Institutes of Health.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below. This proposed information
collection was previously published in the Federal Register on August
22, 2016, pages 56668-9 (81 FR 56668) and allowed 60-days for public
comment. No public comments were received. The purpose of this notice
is to allow an additional 30 days for public comment.
DATES: Comments regarding this information collection are best assured
of having their full effect if received by December 19, 2016.
ADDRESSES: Written comments and/or suggestions regarding the item(s)
contained in this notice, especially regarding the estimated public
burden and associated response time, should be
[[Page 81788]]
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: Desk Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Alyson Ross, Nurse Researcher, Department of
Nursing Research and Translational Science, NIH Clinical Center,
Building 10, Room 2B07, MSC-1151, Bethesda, Maryland, 20892 or call
non-toll-free number (301) 451-8338 or Email your request, including
your address to: Alyson.ross@nih.gov. Formal requests for additional
plans and instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: The NIH Clinical Center, National Institutes
of Health, may not conduct or sponsor, and the respondent is not
required to respond to, an information collection that has been
extended, revised, or implemented on or after October 1, 1995, unless
it displays a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: A National Survey of Nurse Coaches, 0925-NEW,
National Institutes of Health Clinical Center (NIHCC), National
Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of this survey
is to describe the role of Certified Nurse Coaches in order to gain
insight into their clinical practice including: The settings in which
they work, the types of clients/health conditions they see, the types
of client records maintained and outcomes followed, as well as the
personal benefits experienced by nurse coaches as a result of becoming
a nurse coach. It provides information regarding two areas of interest
to the Department of Nursing Research and Translational Science: The
collection of patient-reported outcomes in novel clinical practice
areas and the physical and psychosocial benefits of an intervention in
nurses, a professional caregiver population. This study will provide
preliminary data and guidance in: (1) Developing recommendations for
collecting outcomes to longitudinally assess the effectiveness nurse
coaching, and (2) developing an intervention to improve patient care
and patient satisfaction targeting the nursing staff at the NIH
Clinical Center.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 104.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Certified Nurse Coaches......................... 250 1 25/60 104
---------------------------------------------------------------
Total....................................... 250 250 .............. 104
----------------------------------------------------------------------------------------------------------------
Dated: November 9, 2016.
Laura M. Lee,
Project Clearance Liaison, NIH Clinical Center, National Institutes of
Health.
[FR Doc. 2016-27839 Filed 11-17-16; 8:45 am]
BILLING CODE 4140-01-P
